Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

5th World Congress on Cancer Therapy

Atlanta, USA


Weidong Han

The General Hospital of PLA, China

Biography

Professor Weidong Han, M.D. PhD, is the director of Department of Molecular Immunology/Bio-therapeutic, director of Department of Stem Cell and Tissue Regeneration in Chinese PLA General Hospital. He is a pioneer in the fi eld of tumor immunotherapy, initially developed the clinical translation of chimeric antigen receptor T (CART) cells in China. He holds 10 projects of clinical trial, including 8 registered CART-based trials (CART19, CART20, CART30, CART33, CARTEGFR, CART-HER-2, and CART-138). The corresponding patents were also applied or obtained in China. In recent 10 years, he obtained 9 grants in China and published more than 80 papers on International journals.

Abstract

Abstract : The EGFR- targeted chimeric antigen receptor- modified T cells immunotherapy for patients with EGFR- expressing advanced or relapsed/refractory solid tumors